A LaRue Company, Inc. is an organization that intends to design, patent, and market medical devices. Their primary product, the LaRue Surgical Evacuator, is initially targeted to the surgical breast implant removal and exchange niche market. A LaRue Company, Inc. has two Utility patents and is currently pursuing additional patents for this device. The LaRue Surgical Evacuator is the only patented device designed to remove silicone and other gelatinous materials from the body. This novel and innovative device has been created to meet the needs of plastic surgeons and breast implant patients. The LaRue Surgical Evacuator uses a “Clean Removal Process” to reduce time and increase efficacy to surgeons while optimizing silicone removal for the patient. Utilizing this device provides patients a safe, rapid, and less invasive procedure for removing gelatinous and similar materials from the body or surgical site. The “Clean Removal Process” reduces time for surgeons while minimizing the surgical teams exposure to harmful biohazards, simultaneously providing better outcomes to the patient.
Location: United States, North Carolina, Winston-Salem
Employees: 1-10
Phone: +1 336-255-2148
Total raised: $30K
Founded date: 2019
Investors 1
| Date | Name | Website |
| 13.12.2021 | Health Wil... | healthwild... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 10.11.2021 | Seed | $30K | - |
Mentions in press and media 2
| Date | Title | Description |
| 10.09.2021 | StartUPDATES: New developments from healthcare startups | Emulate this week announced the close of an $82 million Series E financing round led by existing investor Northpond Ventures with additional participation from Perceptive Advisors. With this investment, Emulate has raised nearly $225 millio... |
| - | StartUPDATES: New developments from healthcare startups | Emulate this week announced the close of an $82 million Series E financing round led by existing investor Northpond Ventures with additional participation from Perceptive Advisors. With this investment, Emulate has raised nearly $225 millio... |